S. Baroni, I. Masala, E. Di Nasso, G. Giannaccini, L. Betti, D. Marazziti - Vol. 7, Marzo 2001, num.1
Testo Immagini Bibliografia Summary Riassunto Indice
Recettori piastrinici a2-adrenergici nella depressione
maggiore: correlazione con la sintomatologia
Platelet alpha2-adrenocpetors in major depression: correlation with symptoms
1 American Psychiatric Association Committee on Nomenclature and Statistics.
Diagnostic and Statistical Manual for Mental Disorders. Fourth Edition.
Washington, D.C.: American Psychiatric Press 1994.
2 Arango V, Underwood MD, Mann JJ. Fewer pigmented locus coeruleus neurons
in suicide victims: preliminary results. Biol Psychiatry 1996;39:112-20.
3 Braddock L, Cowen PJ, Elliott JM, Fraser S, Stump K. Binding of yohimbine
and imipramine to platelets in depressive illness. Psychol Med 1986;16:765-73.
4 Brady LS. Stress, antidepressant drugs and the locus coeruleus. Brain
Res Bull 1994;35:545-56.
5 Callado LF, Meana JJ, Grijalba B, Pazos A, Sastre M, Garcia-Sevilla JA.
Selective increase of alpha2A-adrenoceptor agonist binding sites in brains
of depressed suicide victims. J Neurochem 1999;70:1114-23.
6 Corsano S, Strappaghetti G, Barbaro R, Giannaccini G, Betti L, Lucacchini
A. Synthesis of new pyridazinone derivatives and their affinity towards
a1-a2 adrenoceptors. Bioorg & Med Chemi 1999;7:933-41.
7 Daigujii M, Meltzer HY, U’Prichard DC. Human platelet a2-adrenergic receptors:
labelling with 3H-yohimbine, a selective antagonist ligand. Life Sci 1981;28:2705-17.
8 Fillenz M. Noradrenergic neurons. New York: Cambridge University
Press 1990.
9 Garcia-Sevilla JA, Zis AP, Hollingsworth PJ, Greden JF, Smith CB. Platelet
alpha 2-adrenergic receptors in major depressive disorder. Binding of tritiated
clonidine before and after tricyclic antidepressant drug treatment. Arch
Gen Psychiatry 1981;38:1327-33.
10 Garcia-Sevilla JA, Escriba PV, Ozaita A, La Harpe R, Walzer C, Eytan A,
et al. Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling
proteins, and regulatory receptor kinases in the prefrontal cortex of depressed
suicides. J Neurochem 1999;72:282-91.
11 Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry
1960;23:56-62.
12 Kafka MS, Paul SM. Platelet a2-adrenergic receptors in depression. Arch
Gen Psychiatry 1986;43:91-5.
13 Katona CLE, Theodoru AE, Davies SL, et al. 3H-Yohimbine binding to platelet
a2-adrenoceptors in depression. J Affect Disord 1989;17:219-28.
14 Karege F, Bovier P, Widmer J, Gaillard JM, Tissot R. Platelet membrane
alpha 2-adrenergic receptors in depression. Psychiatry Res 1992;43:243-52.
15 Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, et
al. Reduced levels of norepinephrine transporters in the locus coeruleus
in major depression. J Neurosci 1997;17:8451-8.
16 Leonard BE. The role of noradrenaline in depression: a review. J
Psychopharmacol 1997;11(Suppl. 4):39-47.
17 Maas JW Biogenic amines and depression. Arch Gen Psychiatry 1975;32:1357-61.
18 Maes M, Van Gastel A, Delmeire L, Meltzer HY. Decreased platelet alpha-2
adrenoceptor density in major depression: effects of tricyclic antidepressants
and fluoxetine. Biol Psychiatry 1999;45:278-84.
19 Mann J, Underwood M, Arango V Post-mortem studies of suicide victims.
Biology of Schizophrenia. Washington DC: American Psychiatric Press Inc.
1996:197-222.
20 Marazziti D, Calzeroni A, Sacchetti E, et al. Etiopatogenesi della depressione.
In: Trattato Italiano di Psichiatra. Milano: Masson Italia 1998:1843-58.
21 McPherson GA. Kinetic, EBDA, Ligand, Lowry. A collection of radioligand
binding analysis programs. Cambridge: Biosoft 1985.
22 Mendlewicz J, Hirsh D, Sevy S. Alpha2-adrenoceptor binding as a possible
vulnerability marker for affective disorders. Neuropsychobiology 1989;22:61-7.
23 Meana J, Barturen F, Garcia-Sevilla J. Alpha2 adrenoceptors in the brain
of suicide victims. Increased receptor density associated with major depression.
Biol Psychiatry 1992;31:471-90.
24 Muscettola G, Potter WZ, Pickar D, Goodwin FK. Urinary 3-methoxy-4-hydroxyphenylglycol
and major affective disorders: a replication and new findings. Arch Gen
Psychiatry 1984;41:337-42.
25 Peterson GL. A simplification of the protein assay method of Lowry et
al., wich is more generally applicable. Analyt Biochem 1977;83:356-66.
26 Piletz JE, Halaris A. Psychopharmacology of imidazoline and a2-adrenergic
receptors: implications for depression. Crit Rev Neurobiol 1994;9:29-66.
27 Piletz JE, Sletten K. Noradrenergic imidazoline binding sites on human
platelets. J Pharmacol Exp Ther 1993;267:1403-502.
28 Pimoule C, Briley MS, Gay C, Loo H, Sechter D, Zarifian E, et al. 3H-rauwolscine
binding in platelets from depressed patients and healthy volunteers. Psychopharmacology
1983;79:308-12.
29 Potter WZ, Manji HK. Cathecolamines in depression: an update. Clin
Chem 1994;40:279-87.
30 Schatzberg AF, Samson JA, Bloomingdale KL, Orsulak PJ, Gerson B, Kizuka
PP, et al. Toward a biochemical classification of depressive disorders,
X: urinary ctecholamines, their metabolites, and D-type scores in subgroups
of depressive disorders. Arch Gen Psychiatry 1989;46:260-8.
31 Schildkraut JJ, Draskoczy PR, Gershon ES, Reich P, Grab EL. Catecholamine
metabolism in affective disorders. IV. Preliminary studies of norepinephrine
metabolism in depressed patients treated with amitriptyline. J Psychiat
Res 1972;9:173-85.
32 Southwick SM, Yehuda R, Giller EL, Perry BD. Platelet alpha 2-adrenergic
receptor binding sites in major depressive disorder and borderline personality
disorder. Psychiaty Res 1990;34:193-203.
33 Spyraki C, Fibiger H. Functional evidence for subsensitivity of noradrenergic
alpha2 receptors after chronic desipramine treatment. Life Sci 1980;27:1866-7.
34 Wood K, Coppen A Platelet a-adrenergic sensitivity in depressive illness.